John Barton, DO
Surgery · Cameron, MONPI 1942284674
Payments from drug & device makers
Across 77 payments — averaging $19.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$292
- Mylan Specialty L.p.$214
- Astellas Pharma US Inc$103
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$96
- Baudax Bio Inc.$89
- Lilly USA, LLC$77
- plus $633 from 20 others
What the payments were for
- Food & beverage$1,505100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 12 | $292 |
| Mylan Specialty L.p. | 14 | $214 |
| Astellas Pharma US Inc | 5 | $103 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $96 |
| Baudax Bio Inc. | 5 | $89 |
| Lilly USA, LLC | 5 | $77 |
| Novo Nordisk | 4 | $62 |
| Olympus Corporation Of The Americas | 1 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Sanofi Pasteur Inc. | 2 | $46 |
| Melinta Therapeutics, LLC | 2 | $45 |
| Daiichi Sankyo Inc. | 1 | $35 |
| Abbott | 2 | $35 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| AstraZeneca | 1 | $29 |
| Tetraphase Pharmaceuticals, Inc. | 2 | $29 |
| Genentech USA, Inc. | 2 | $28 |
| Sunovion Pharmaceuticals Inc. | 1 | $28 |
| Exact Sciences | 1 | $27 |
| Vertex | 1 | $26 |
| Merck | 1 | $24 |
| GSK | 1 | $22 |
| Viatris Specialty LLC | 1 | $21 |
| Johnson & Johnson | 1 | $19 |
| Kedrion Biopharma, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$1,505 in reported general payments places this provider in the 45th percentile of 612 surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 126 | $3,824 |
| Fentanyl | 22 | $2,439 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 23 | $721 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 19 | $476 |
| Gabapentin | 35 | $385 |
| Celecoxib | 31 | $302 |
| Omeprazole | 27 | $292 |
| Atorvastatin Calcium | 22 | $256 |
| Tramadol Hcl | 62 | $246 |
| Levothyroxine Sodium | 14 | $246 |
| Donepezil Hcl | 26 | $243 |
| Oxycodone Hcl | 25 | $192 |
| Methylprednisolone | 18 | $137 |
| Lisinopril | 41 | $136 |
| Alprazolam | 39 | $131 |
Paid to pharmacies, not to this prescriber.
Other surgery in Cameron
- Tiffany OsbornSaint Louis$493K
- Jeffrey BlatnikSaint Louis$422K
- Varun PuriSaint Louis$346K
- Victor VidalsKansas City$327K
- James ScottSaint Louis$307K
- Andrew WheelerColumbia$298K
- Omar GuerraSaint Louis$249K
- Michael AwadSaint Louis$248K
- Carl FreemanSaint Louis$233K
- John TannColumbia$216K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.